Skip to main content

Together we are beating cancer

Donate now

Women

Showing 2 out of 98 results
Cancer Research UK logo

A new breast cancer drug, tipped to replace tamoxifen as the gold standard hormone treatment, also has the potential to prevent or delay up to 80 per cent of breast tumours in most high risk post-menopausal women. A new breast cancer drug, tipped to replace tamoxifen as the gold standard hormone treatment, also has the potential to prevent or delay up to 80 per cent of breast tumours in most high risk post-menopausal women.

by Cancer Research UK | News | 20 June 2002

20 June 2002

Cancer Research UK logo

Women who have an identical twin sister with breast cancer are at least three times more likely than average to develop the disease, a leading Cancer Research UK scientist will tell fellow experts. Women who have an identical twin sister with breast cancer are at least three times more likely than average to develop the disease, a leading Cancer Research UK scientist will tell fellow experts.

by Cancer Research UK | News | 4 May 2002

4 May 2002